# Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy

> **NCT03166904** · PHASE2 · WITHDRAWN · sponsor: **Samsung Medical Center**

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Vistusertib(AZD2014)

## Key facts

- **NCT ID:** NCT03166904
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-03
- **Primary completion:** 2018-06
- **Final completion:** 2018-07-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of efficacy
- **Last updated:** 2019-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03166904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03166904, "Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03166904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*